Titelia

Funds holding ALBIREO PHARMA INC CVR

ISIN US013CVR0225 · United States

Fund holders
6
Of which ETFs
4 2 other funds
Value held
313.8K $
FundSharesValueWeight in fund
Dimensional U.S. Small Cap ETF Dimensional ETF Trust 32,677208.5K $0.00 %as of Jul 31, 2026 ↗
Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust 10,64867.9K $0.00 %as of Jul 31, 2026 ↗
Dimensional U.S. Equity Market ETF Dimensional ETF Trust 2,67417.1K $0.00 %as of Jul 31, 2026 ↗
Victory Extended Market Index Fund Victory Portfolios III 2,0704.5K $0.00 %as of Jul 31, 2026 ↗
Dimensional US Core Equity Market ETF Dimensional ETF Trust 1,2668.1K $0.00 %as of Jul 31, 2026 ↗
AZL DFA U.S. Core Equity Fund Allianz Variable Insurance Products Trust 1,2627.8K $0.00 %as of Jun 30, 2026 ↗

Download this table: CSV, JSON

Report an error

The funds most exposed to it

The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.

FundWeight in fund
Dimensional U.S. Small Cap ETF Dimensional ETF Trust 0.00 %as of Jul 31, 2026 ↗
AZL DFA U.S. Core Equity Fund Allianz Variable Insurance Products Trust 0.00 %as of Jun 30, 2026 ↗
Victory Extended Market Index Fund Victory Portfolios III 0.00 %as of Jul 31, 2026 ↗
Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust 0.00 %as of Jul 31, 2026 ↗
Dimensional U.S. Equity Market ETF Dimensional ETF Trust 0.00 %as of Jul 31, 2026 ↗
Dimensional US Core Equity Market ETF Dimensional ETF Trust 0.00 %as of Jul 31, 2026 ↗

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterHoldersChangeSharesChange
2026Q36050,5970.0 %
2026Q26050,5970.0 %
2026Q16-150,597-42.8 %
2025Q47088,4500.0 %
2025Q37088,4500.0 %
2025Q27088,4500.0 %
2025Q17088,4500.0 %
2024Q47088,4500.0 %
2024Q37088,4500.0 %
2024Q27088,4500.0 %
2024Q17088,4500.0 %
2023Q4788,450
Cite this page

Titelia. "Funds holding ALBIREO PHARMA INC CVR". https://titelia.com/en/stocks/albireo-pharma-inc-cvr-US013CVR0225